# Olympus Innovation Ventures

Olympus Innovation Ventures is a Venture Capital based in Westborough, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Westborough, United States
- **Region:** North America
- **Address:** Westborough, MA, United States
- **Founded:** 2022
- **Assets under management:** Undisclosed
- **Website:** olympus-innovation.com
- **LinkedIn:** https://www.linkedin.com/company/olympus-innovation-ventures

## Regulatory record

- **Reports private funds:** No

## About

Olympus Innovation Ventures invests in customer driven solutions in medical devices, diagnostics and digital health that complement or extend Olympus market leading endoscopic solutions. The firm helps innovative startups create competitive advantage through advice, promotion and partnership with Olympus. Entrepreneurs benefit from Olympus technical and clinical expertise, scale and relationships with healthcare systems across the globe.

## Sectors

- Digital Health
- Robotics & Automation
- Healthcare Services
- AI/ML

## People

- Gabriela Kaynor — Chair of Investment Committee, Chief Strategy Officer of Olympus Corporation
- Abigail Hunter-Syed — Director
- Yasuo Takeuchi — CEO, Olympus Corporation
- Nacho Abia — COO, Olympus Corporation

## Questions

### Who runs investment decisions at Olympus Innovation Ventures?

An investment committee chaired by Gabriela Kaynor, Olympus Corporation's Chief Strategy Officer, governs the fund. Day-to-day operations are managed by Director Abigail Hunter-Syed. The structure embeds corporate strategy and R&D leadership directly into capital allocation, distinguishing it from an independent GP model where LPs hold primary governance.

### How does Olympus Innovation Ventures source proprietary deal flow?

Sourcing leverages Olympus's installed base of over 10,000 clinical sites globally. This network provides early signal on unmet procedural needs and direct KOL introductions to startups addressing them. The firm's relationship with Olympus Medical Systems' engineering teams additionally surfaces technical founders before they formally go to market.

### Does Olympus Innovation Ventures participate in fund commitments or only direct deals?

OIV exclusively pursues direct equity investments in early- to growth-stage operating companies. There is no public record of the firm deploying capital into external fund vehicles or engaging in secondaries. Its mandate is to expand the parent's technology adjacencies through direct startup exposure.

### Which sectors does Olympus Innovation Ventures explicitly avoid?

The firm has not publicly articulated negative screens, but its disclosed portfolio and parent focus suggest it will not allocate to therapeutic pharmaceuticals, medical aesthetics without an adjacent diagnostic or procedural-tech angle, or pure consumer-health apps outside the clinical workflow integration space it prioritizes.

### Where does the underlying capital for Olympus Innovation Ventures come from?

Capital comes directly from Olympus Corporation's corporate balance sheet. The entity that founded OIV—Olympus Corporation of the Americas, led originally by CEO Yasuo Takeuchi and COO Nacho Abia—allocates strategic investment dollars through this wholly owned vehicle. There is no outside LP fundraising.

## Related profiles

- [Olympic Valley Capital](https://altss.com/profile/olympic-valley-capital)
- [Omphalos Ventures India](https://altss.com/profile/omphalos-ventures-india)

---

Last updated: 2026-08-11T15:07:41.444Z

Canonical page: https://altss.com/profile/olympus-innovation-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology